Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMMX Immix Biopharma, Inc

休市中 07-26 16:00:00 EDT

2.24

+0.09

+4.19%

盘后2.25

+0.01+0.45%

19:49 EDT

最高2.30	最低2.15	成交量12.56万
今开2.16	昨收2.15	日振幅6.94%
总市值5,917万	流通市值2,992万	总股本2,641万
成交额27.90万	换手率0.94%	流通股本1,336万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMMX","market":"US","secType":"STK","nameCN":"Immix Biopharma, Inc","latestPrice":2.24,"timestamp":1722024000000,"preClose":2.15,"halted":0,"volume":125563,"hourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.24,"latestTime":"19:49 EDT","volume":521,"amount":1168.3,"timestamp":1722037789343},"delay":0,"floatShares":13358717,"shares":26414300,"eps":-0.922894,"marketStatus":"休市中","marketStatusCode":7,"change":0.09,"latestTime":"07-26 16:00:00 EDT","open":2.16,"high":2.3,"low":2.1507,"amount":279005.16724790004,"amplitude":0.069442,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.922894,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1639630800000,"adjPreClose":2.15,"preHourTrading":{"tag":"盘前","latestPrice":2.28,"preClose":2.15,"latestTime":"09:20 EDT","volume":5917,"amount":13130.874450899999,"timestamp":1722000011606},"postHourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.24,"latestTime":"19:49 EDT","volume":521,"amount":1168.3,"timestamp":1722037789343},"volumeRatio":1.725302085063412,"impliedVol":0.7075,"impliedVolPercentile":0.0234},"requestUrl":"/m/hq/s/IMMX","defaultTab":"news","newsList":[{"id":"2454736263","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454736263","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454736263?lang=zh_cn&edition=full","pubTime":"2024-07-27 00:47","pubTimestamp":1722012475,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日00时47分，Immix Biopharma, Inc.股票出现异动，股价急速上涨5.12%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为5606.43%、210.57%、152.57%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Cel-Sci Corporation，振幅分别为182.50%、98.48%、91.73%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072700475596820d93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072700475596820d93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2454938852","title":"Immix Biopharma, Inc.盘中异动 快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454938852","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454938852?lang=zh_cn&edition=full","pubTime":"2024-07-26 02:06","pubTimestamp":1721930769,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日02时06分，Immix Biopharma, Inc.股票出现异动，股价快速拉升5.10%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃，换手率分别为4886.23%、585.22%、290.98%，振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为158.05%、140.39%、98.60%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072602060996820628&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072602060996820628&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2453791787","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.22%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453791787","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453791787?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:58","pubTimestamp":1721660282,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时58分，Immix Biopharma, Inc.股票出现波动，股价大幅上涨5.22%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Mei Pharma, Inc.、木薯科学涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Mei Pharma, Inc.较为活跃，换手率分别为115.27%、98.58%、52.16%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Anew Medical Inc C/Wts 21/06/2029 、木薯科学，振幅分别为44.26%、44.07%、33.41%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722225802aefacc5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722225802aefacc5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2452293471","title":"Immix Biopharma, Inc.盘中异动 早盘股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452293471","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452293471?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:58","pubTimestamp":1721397485,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时58分，Immix Biopharma, Inc.股票出现异动，股价急速拉升5.37%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为1066.31%、554.50%、251.33%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Altamira Therapeutics Ltd.，振幅分别为82.03%、62.56%、24.63%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719215805aefa8abd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719215805aefa8abd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2452160049","title":"Immix Biopharma, Inc.盘中异动 快速拉升5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452160049","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452160049?lang=zh_cn&edition=full","pubTime":"2024-07-18 01:26","pubTimestamp":1721237215,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日01时26分，Immix Biopharma, Inc.股票出现异动，股价快速拉升5.37%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为2.26%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3688.05%、1398.53%、299.31%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、4D Molecular Therapeutics, Inc.，振幅分别为76.39%、46.25%、45.71%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718012655aefa2946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718012655aefa2946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2450258920","title":"Immix Biopharma, Inc.盘中异动 早盘大幅拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450258920","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450258920?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:03","pubTimestamp":1720533820,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时03分，Immix Biopharma, Inc.股票出现波动，股价快速上涨5.09%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。其相关个股中，Soligenix, Inc.、Uniqure N.V.、Longeveron Inc.涨幅较大，Soligenix, Inc.、Anew Medical, Inc.、Longeveron Inc.较为活跃，换手率分别为5082.81%、122.24%、96.22%，振幅较大的相关个股有Soligenix, Inc.、Longeveron Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为167.50%、38.02%、33.17%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709220341941f5710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709220341941f5710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2449705515","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449705515","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449705515?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:44","pubTimestamp":1720446282,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时44分，Immix Biopharma, Inc.股票出现异动，股价快速下跌5.08%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Morphic Holding, Inc.、Virpax Pharmaceuticals, Inc.、Kineta, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为552.18%、149.89%、123.37%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为65.74%、33.33%、32.66%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082144429681aa7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082144429681aa7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2446284991","title":"Immix Biopharma, Inc.盘中异动 大幅拉升7.46%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446284991","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446284991?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:33","pubTimestamp":1719322406,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时33分，Immix Biopharma, Inc.股票出现波动，股价快速拉升7.46%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大，Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为86.41%、83.78%、57.56%，振幅较大的相关个股有Glycomimetics, Inc.、Lipella Pharmaceuticals Inc.、Unicycive Therapeutics, Inc.，振幅分别为15.94%、12.48%、12.16%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521332696816a14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521332696816a14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2445791537","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445791537","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445791537?lang=zh_cn&edition=full","pubTime":"2024-06-22 03:41","pubTimestamp":1718998917,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日03时41分，Immix Biopharma, Inc.股票出现异动，股价快速上涨5.20%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622034157941f02c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622034157941f02c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2444674243","title":"Immix Biopharma, Inc.盘中异动 早盘股价大跌5.97%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444674243","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444674243?lang=zh_cn&edition=full","pubTime":"2024-06-20 22:50","pubTimestamp":1718895006,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日22时50分，Immix Biopharma, Inc.股票出现波动，股价快速下跌5.97%。截至发稿，该股报1.89美元/股，成交量2.0269万股，换手率0.08%，振幅5.78%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。其候选产品包括治疗自身免疫性疾病的 CAR-T NXC-201 和治疗软组织肉瘤的 IMX-110。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620225007aef5dc73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620225007aef5dc73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2444195273","title":"Immix Biopharma, Inc.盘中异动 急速拉升9.22%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444195273","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444195273?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:49","pubTimestamp":1718635774,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时49分，Immix Biopharma, Inc.股票出现波动，股价急速拉升9.22%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Gossamer Bio, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为4344.47%、1106.09%、143.33%，振幅较大的相关个股有Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Sellas Life Sciences Group, Inc.，振幅分别为163.08%、46.42%、29.99%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617224934af8de4fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617224934af8de4fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2442684885","title":"Immix Biopharma, Inc.盘中异动 快速拉升5.39%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442684885","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442684885?lang=zh_cn&edition=full","pubTime":"2024-06-12 22:24","pubTimestamp":1718202261,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日22时24分，Immix Biopharma, Inc.股票出现异动，股价大幅拉升5.39%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为79.16%、30.55%、11.07%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Revelation Biosciences Inc C/Wts 10/01/2027 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为85.53%、52.56%、51.41%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612222422aef49934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612222422aef49934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2441772648","title":"Immix Biopharma, Inc.盘中异动 下午盘大幅下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441772648","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441772648?lang=zh_cn&edition=full","pubTime":"2024-06-07 02:46","pubTimestamp":1717699600,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日02时46分，Immix Biopharma, Inc.股票出现异动，股价大幅下挫5.29%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Virax Biolabs Group Limited、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Fibrobiologics, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为3199.94%、85.28%、56.67%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virax Biolabs Group Limited、Fibrobiologics, Inc.，振幅分别为129.76%、87.85%、70.00%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607024640af8c6fc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607024640af8c6fc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2441710132","title":"Immix Biopharma, Inc.盘中异动 急速拉升8.84%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441710132","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441710132?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:50","pubTimestamp":1717595432,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时50分，Immix Biopharma, Inc.股票出现波动，股价大幅上涨8.84%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Vir Biotechnology, Inc.、Eliem Therapeutics, Inc涨幅较大，Adial Pharmaceuticals, Inc、Cns Pharmaceuticals, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为44.77%、21.19%、7.21%，振幅较大的相关个股有Silo Pharma, Inc.、Cns Pharmaceuticals, Inc.、Maia Biotechnology, Inc.，振幅分别为23.56%、22.81%、19.57%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605215032af8c28cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605215032af8c28cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2440411744","title":"Immix Biopharma, Inc.盘中异动 下午盘股价大跌5.60%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440411744","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440411744?lang=zh_cn&edition=full","pubTime":"2024-06-04 03:21","pubTimestamp":1717442461,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日03时21分，Immix Biopharma, Inc.股票出现波动，股价急速下跌5.60%。截至发稿，该股报1.99美元/股，成交量6.7275万股，换手率0.25%，振幅7.82%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。其候选产品包括治疗自身免疫性疾病的 CAR-T NXC-201 和治疗软组织肉瘤的 IMX-110。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604032102af8bb9a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604032102af8bb9a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2439506744","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439506744","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439506744?lang=zh_cn&edition=full","pubTime":"2024-05-30 01:58","pubTimestamp":1717005484,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日01时58分，Immix Biopharma, Inc.股票出现波动，股价急速下挫5.19%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。其相关个股中，Onconetix, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Mustang Bio, Inc.、Onconetix, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为533.84%、378.31%、112.44%，振幅较大的相关个股有Onconetix, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为228.43%、117.00%、50.40%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530015804941eaf03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530015804941eaf03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2437035212","title":"Immix Biopharma, Inc.盘中异动 下午盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437035212","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437035212?lang=zh_cn&edition=full","pubTime":"2024-05-23 02:42","pubTimestamp":1716403333,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日02时42分，Immix Biopharma, Inc.股票出现异动，股价快速下挫5.43%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、180 Life Sciences Corp C/Wts 07/11/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Gt Biopharma, Inc.较为活跃，换手率分别为347.12%、172.48%、57.07%，振幅较大的相关个股有Mustang Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts ，振幅分别为61.52%、57.14%、48.75%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523024213861ee62a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523024213861ee62a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2435435845","title":"Immix Biopharma, Inc.盘中异动 大幅上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435435845","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435435845?lang=zh_cn&edition=full","pubTime":"2024-05-15 00:05","pubTimestamp":1715702726,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日00时05分，Immix Biopharma, Inc.股票出现异动，股价快速上涨5.56%。截至发稿，该股报2.28美元/股，成交量6.5417万股，换手率0.25%，振幅5.56%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150005277927a1e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150005277927a1e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2433789503","title":"Immix Biopharma, Inc.盘中异动 早盘大幅跳水5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789503","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433789503?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:47","pubTimestamp":1715093231,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时47分，Immix Biopharma, Inc.股票出现波动，股价急速下跌5.58%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，珐博进、Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为1391.24%、169.03%、167.61%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、珐博进、Clearmind Medicine Inc.，振幅分别为41.69%、41.38%、37.61%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722471179264d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722471179264d68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2432988757","title":"Immix Biopharma, Inc.盘中异动 早盘大幅上涨6.91%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432988757","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432988757?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:49","pubTimestamp":1714661357,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时49分，Immix Biopharma, Inc.股票出现异动，股价快速上涨6.91%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Allarity Therapeutics, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为3491.99%、548.88%、141.77%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Aptevo Therapeutics Inc.，振幅分别为126.28%、52.87%、33.33%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502224917861eab56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502224917861eab56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immixbio.com","stockEarnings":[{"period":"1week","weight":0.0769},{"period":"1month","weight":0.0182},{"period":"3month","weight":0.0516},{"period":"6month","weight":-0.4151},{"period":"1year","weight":0.1089},{"period":"ytd","weight":-0.6763}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immix Biopharma, Inc.于2014年1月7日成立为特拉华州公司。该公司是一家临床阶段的生物制药公司，在肿瘤学和炎症领域开发一种新型的组织特异性疗法（“TSTx”）TM。该公司的主要资产IMX-110目前正在美国和澳大利亚进行实体瘤的1b/2a期临床试验。","exchange":"NASDAQ","name":"Immix Biopharma, Inc","nameEN":"Immix Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immix Biopharma, Inc(IMMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immix Biopharma, Inc,IMMX,Immix Biopharma, Inc股票,Immix Biopharma, Inc股票老虎,Immix Biopharma, Inc股票老虎国际,Immix Biopharma, Inc行情,Immix Biopharma, Inc股票行情,Immix Biopharma, Inc股价,Immix Biopharma, Inc股市,Immix Biopharma, Inc股票价格,Immix Biopharma, Inc股票交易,Immix Biopharma, Inc股票购买,Immix Biopharma, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immix Biopharma, Inc(IMMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}